scholarly article | Q13442814 |
P50 | author | Marc Blondel | Q56423155 |
Henri Gruffat | Q61106762 | ||
Evelyne Manet | Q43113835 | ||
P2093 | author name string | Pierre Busson | |
Robin Fahraeus | |||
Joanna B Wilson | |||
P2860 | cites work | HMG1 and 2: architectural DNA-binding proteins | Q22121969 |
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization | Q24292930 | ||
ORC binding to TRF2 stimulates OriP replication | Q24294674 | ||
Molecular recognition of p53 and MDM2 by USP7/HAUSP | Q24304312 | ||
RNA-dependent recruitment of the origin recognition complex | Q24336965 | ||
EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance. | Q24517055 | ||
EBP2 plays a key role in Epstein-Barr virus mitotic segregation and is regulated by aurora family kinases | Q24529069 | ||
Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice | Q24562912 | ||
An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions | Q24614360 | ||
Global mapping of c-Myc binding sites and target gene networks in human B cells | Q24675083 | ||
EBNA1 partitions Epstein-Barr virus plasmids in yeast cells by attaching to human EBNA1-binding protein 2 on mitotic chromosomes | Q24675498 | ||
The GTPase Ran regulates chromosome positioning and nuclear envelope assembly in vivo. | Q52122308 | ||
Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2. | Q54228841 | ||
Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx | Q56689988 | ||
Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F | Q73925270 | ||
Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing | Q74045603 | ||
The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line | Q74083363 | ||
Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China | Q84821085 | ||
Epstein-Barr virus and gastric carcinoma | Q93889525 | ||
Epstein-Barr virus nuclear antigen-1 renders lymphocytes responsive to IL-2 but not IL-15 for survival. | Q45389759 | ||
Epstein-Barr virus induces cellular transcription factors to allow active expression of EBER genes by RNA polymerase III. | Q45412522 | ||
DNA looping between sites for transcriptional activation: self-association of DNA-bound Sp1 | Q45715501 | ||
Complex protein-DNA dynamics at the latent origin of DNA replication of Epstein-Barr virus | Q45721968 | ||
Reactivity with A monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome | Q45723747 | ||
Demonstration of Epstein-Barr virus in carcinomas of various sites | Q45731119 | ||
Telomeric proteins regulate episomal maintenance of Epstein-Barr virus origin of plasmid replication | Q45733048 | ||
Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas | Q45769710 | ||
Identification of Epstein-Barr virus nuclear antigen 1 protein domains that direct interactions at a distance between DNA-bound proteins | Q45772573 | ||
Stabilization of the EBNA1 protein on the Epstein-Barr virus latent origin of DNA replication by a DNA looping mechanism. | Q45776796 | ||
Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease | Q45782539 | ||
Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells. | Q45820444 | ||
Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies | Q45826475 | ||
Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines | Q45826585 | ||
Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. | Q45841044 | ||
The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication | Q45845623 | ||
Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein-Barr virus | Q45854874 | ||
PI3Kδ activates E2F1 synthesis in response to mRNA translation stress | Q47117105 | ||
Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. | Q36828339 | ||
Telomere Repeat Binding Factors TRF1, TRF2, and hRAP1 Modulate Replication of Epstein-Barr Virus OriP | Q36890221 | ||
A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components | Q36891387 | ||
trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. | Q36899288 | ||
The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4 | Q36994613 | ||
The c-myc promoter: still MysterY and challenge | Q37013896 | ||
mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1 | Q37051602 | ||
Identifying sites bound by Epstein-Barr virus nuclear antigen 1 (EBNA1) in the human genome: defining a position-weighted matrix to predict sites bound by EBNA1 in viral genomes | Q37127891 | ||
Gly-Ala repeats induce position- and substrate-specific regulation of 26 S proteasome-dependent partial processing | Q37142562 | ||
One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain | Q37349287 | ||
Phosphorylation sites of Epstein-Barr virus EBNA1 regulate its function | Q37450613 | ||
Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription | Q37475294 | ||
EBNA1 binding and epigenetic regulation of gastrokine tumor suppressor genes in gastric carcinoma cells | Q37524565 | ||
p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia | Q37535238 | ||
Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen | Q37560230 | ||
The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes | Q37583383 | ||
PI3Kδ and primary immunodeficiencies. | Q37623828 | ||
Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome | Q37660246 | ||
A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus | Q37682377 | ||
Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers | Q38245881 | ||
The chromatin structure of the dual c-myc promoter P1/P2 is regulated by separate elements | Q38302512 | ||
Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells | Q38306265 | ||
Binding of myc proteins to canonical and noncanonical DNA sequences | Q38316286 | ||
Stabilization of E2F1 protein by MDM2 through the E2F1 ubiquitination pathway | Q38320884 | ||
High affinity interactions of nucleolin with G-G-paired rDNA. | Q38324508 | ||
G4 DNA binding by LR1 and its subunits, nucleolin and hnRNP D, A role for G-G pairing in immunoglobulin switch recombination | Q38329955 | ||
Sequence-specific DNA binding by the c-Myc protein | Q38338266 | ||
Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors | Q38340868 | ||
Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, EBNA1, bound to DNA. | Q38360539 | ||
Phosphatidylinositol 3-kinase potentiates, but does not trigger, T cell proliferation mediated by the IL-2 receptor | Q38524452 | ||
The long-lasting love affair between the budding yeast Saccharomyces cerevisiae and the Epstein-Barr virus | Q38574687 | ||
Humanized mouse models for Epstein Barr virus infection | Q38637726 | ||
Recent advances in viral evasion of the MHC Class I processing pathway | Q38804445 | ||
The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold | Q24685733 | ||
Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway | Q25255608 | ||
Structure of RCC1 chromatin factor bound to the nucleosome core particle | Q27664183 | ||
Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein EBNA 1 | Q27729477 | ||
The 2.2 A structure of a permanganate-sensitive DNA site bound by the Epstein-Barr virus origin binding protein, EBNA1 | Q27766425 | ||
Modulation of the p53/MDM2 interplay by HAUSP inhibitors | Q28075457 | ||
Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP | Q28204725 | ||
Epstein-Barr virus U leader exon contains an internal ribosome entry site | Q28205747 | ||
Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin | Q28213116 | ||
Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization | Q28243346 | ||
A dynamic role of HAUSP in the p53-Mdm2 pathway | Q28253645 | ||
Tumour suppression: disruption of HAUSP gene stabilizes p53 | Q28254102 | ||
Signaling by the phosphoinositide 3-kinase family in immune cells | Q28283677 | ||
HAUSP/USP7 as an Epstein-Barr virus target | Q28288651 | ||
New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway | Q28608965 | ||
RCC1 uses a conformationally diverse loop region to interact with the nucleosome: a model for the RCC1-nucleosome complex | Q28910442 | ||
A systems analysis of importin-{alpha}-{beta} mediated nuclear protein import | Q30436382 | ||
The genetic landscape of mutations in Burkitt lymphoma | Q30453771 | ||
Ran GTPase cycle and importins alpha and beta are essential for spindle formation and nuclear envelope assembly in living Caenorhabditis elegans embryos | Q30476914 | ||
Interaction between basic residues of Epstein-Barr virus EBNA1 protein and cellular chromatin mediates viral plasmid maintenance | Q30543103 | ||
Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. | Q30941966 | ||
Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules | Q32063827 | ||
Human RPA (hSSB) interacts with EBNA1, the latent origin binding protein of Epstein-Barr virus | Q32156436 | ||
Zinc coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1 | Q33466782 | ||
EBNA1 regulates cellular gene expression by binding cellular promoters | Q33563969 | ||
Promoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2. | Q33604108 | ||
Pathways of antigen processing | Q33631854 | ||
Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas. | Q33640115 | ||
Transcription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexes | Q33656437 | ||
Epstein-Barr virus provides a survival factor to Burkitt's lymphomas | Q33716529 | ||
Epstein Barr Virus-Encoded EBNA1 Interference with MHC Class I Antigen Presentation Reveals a Close Correlation between mRNA Translation Initiation and Antigen Presentation | Q33728510 | ||
Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. | Q40399583 | ||
Eradication of Epstein-Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1. | Q40445894 | ||
Protein and sequence requirements for the recruitment of the human origin recognition complex to the latent cycle origin of DNA replication of Epstein-Barr virus oriP. | Q40527147 | ||
Epstein-Barr virus nuclear antigen 1 (EBNA1) induced cytotoxicity in epithelial cells is associated with EBNA1 degradation and processing | Q40637962 | ||
Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling | Q40687983 | ||
HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus | Q40742979 | ||
Regulation of c-myc transcription by interleukin-2 (IL-2). Identification of a novel IL-2 response element interacting with STAT-4. | Q40897143 | ||
The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells | Q41112391 | ||
Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1-binding protein 2 (EBP2) | Q41370670 | ||
Identification of integrated Epstein-Barr virus in nasopharyngeal carcinoma using pulse field gel electrophoresis | Q41494156 | ||
Epstein-Barr nuclear antigen 1 (EBNA1)-dependent recruitment of origin recognition complex (Orc) on oriP of Epstein-Barr virus with purified proteins: stimulation by Cdc6 through its direct interaction with EBNA1. | Q41818409 | ||
Nucleophosmin contributes to the transcriptional activation function of the Epstein-Barr virus EBNA1 protein | Q41908850 | ||
Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection | Q42019706 | ||
The latent origin of replication of Epstein-Barr virus directs viral genomes to active regions of the nucleus | Q42118228 | ||
Modelling the structure of full-length Epstein-Barr virus nuclear antigen 1. | Q42206678 | ||
Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing | Q42244791 | ||
A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: a new mechanism for selective inhibition of proteolysis | Q42459737 | ||
bcl-xL and RAG genes are induced and the response to IL-2 enhanced in EmuEBNA-1 transgenic mouse lymphocytes. | Q42681249 | ||
Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line | Q42817375 | ||
EBNA1 efficiently assembles on chromatin containing the Epstein-Barr virus latent origin of replication | Q43505203 | ||
Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region | Q44286183 | ||
Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. | Q44575280 | ||
Epstein-Barr-encoded RNA in situ hybridization: diagnostic applications | Q44895986 | ||
Small molecule and peptide-mediated inhibition of Epstein-Barr virus nuclear antigen 1 dimerization | Q45356566 | ||
Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis | Q36204234 | ||
Transcriptional regulation and transformation by Myc proteins | Q36215755 | ||
A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells | Q36263086 | ||
Dual Roles of MDM2 in the Regulation of p53: Ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 Activity | Q36387594 | ||
Splicing up mdm2 for cancer proteome diversity | Q36387622 | ||
Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1. | Q36399179 | ||
Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival | Q36433955 | ||
Interaction between HMGA1a and the origin recognition complex creates site-specific replication origins | Q36446490 | ||
Metaphase chromosome tethering is necessary for the DNA synthesis and maintenance of oriP plasmids but is insufficient for transcription activation by Epstein-Barr nuclear antigen 1. | Q36541024 | ||
Initiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined origin | Q36551194 | ||
EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication | Q36656334 | ||
c-Myc enhances protein synthesis and cell size during B lymphocyte development | Q36668198 | ||
Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. | Q36682530 | ||
The Epstein-Barr virus nuclear antigen-1 reprograms transcription by mimicry of high mobility group A proteins | Q36684853 | ||
Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells | Q36688190 | ||
Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts | Q36696963 | ||
Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition. | Q36756835 | ||
Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites | Q36779998 | ||
Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA | Q36806138 | ||
A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. | Q36828303 | ||
Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism. | Q33733617 | ||
Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines | Q33784685 | ||
Functional analyses of the EBNA1 origin DNA binding protein of Epstein-Barr virus | Q33787020 | ||
Epstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan | Q33847952 | ||
The replicator of the Epstein-Barr virus latent cycle origin of DNA replication, oriP, is composed of multiple functional elements | Q33848552 | ||
Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA | Q33891292 | ||
Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA. | Q33907682 | ||
Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus | Q33942957 | ||
EBV latency types adopt alternative chromatin conformations | Q33987454 | ||
Developments in Burkitt's lymphoma: novel cooperations in oncogenic MYC signaling | Q34039568 | ||
The Rb/E2F pathway: expanding roles and emerging paradigms | Q34052659 | ||
Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1. | Q34107917 | ||
Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer | Q34261764 | ||
Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. | Q34294106 | ||
G-quadruplexes regulate Epstein-Barr virus-encoded nuclear antigen 1 mRNA translation | Q34303299 | ||
Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1. | Q34332147 | ||
Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway | Q34347586 | ||
Translocations involving c-myc and c-myc function | Q34405431 | ||
Premature chromosome condensation is induced by a point mutation in the hamster RCC1 gene | Q34419033 | ||
Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB. | Q34467720 | ||
The myc oncogene: MarvelouslY Complex | Q34555987 | ||
Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells | Q34564031 | ||
Regulation of the EBNA1 Epstein-Barr virus protein by serine phosphorylation and arginine methylation | Q34648403 | ||
Emerging roles of E2Fs in cancer: an exit from cell cycle control | Q35009182 | ||
Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells | Q35076361 | ||
Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes | Q35080523 | ||
Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx | Q35119129 | ||
Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma | Q35603098 | ||
An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene | Q35838226 | ||
oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. | Q35867579 | ||
Live-cell imaging reveals multiple interactions between Epstein-Barr virus nuclear antigen 1 and cellular chromatin during interphase and mitosis | Q35943704 | ||
The AT-hook DNA binding ability of the Epstein Barr virus EBNA1 protein is necessary for the maintenance of viral genomes in latently infected cells | Q36052985 | ||
Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design | Q36072450 | ||
Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival | Q36141691 | ||
The V-val subtype Epstein-Barr virus nuclear antigen 1 promotes cell survival after serum withdrawal. | Q38936952 | ||
Mechanisms and regulation of DNA replication initiation in eukaryotes | Q39017132 | ||
Efficient replication of Epstein-Barr virus-derived plasmids requires tethering by EBNA1 to host chromosomes | Q39091793 | ||
The linking regions of EBNA1 are essential for its support of replication and transcription | Q39445473 | ||
Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma | Q39455578 | ||
RP-MDM2-p53 Pathway: Linking Ribosomal Biogenesis and Tumor Surveillance | Q39456968 | ||
Coupling of mitotic chromosome tethering and replication competence in epstein-barr virus-based plasmids | Q39530529 | ||
Expression of epstein-barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428. | Q39549562 | ||
Mapping EBNA-1 domains involved in binding to metaphase chromosomes. | Q39550682 | ||
Expression of epstein-barr virus encoded nuclear antigen 1 in benign and malignant tissues harbouring EBV. | Q39599529 | ||
Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines | Q39603122 | ||
Replication from oriP of Epstein-Barr virus requires exact spacing of two bound dimers of EBNA1 which bend DNA. | Q39604900 | ||
Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines | Q39612332 | ||
Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin | Q39629572 | ||
Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1). | Q39647281 | ||
E2F1 inhibits MDM2 expression in a p53-dependent manner. | Q39656469 | ||
Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies | Q39666008 | ||
Reconstitution of Epstein-Barr virus-based plasmid partitioning in budding yeast | Q39696990 | ||
Mechanistic studies on the DNA linking activity of Epstein-Barr nuclear antigen 1. | Q39725201 | ||
Computational analysis of EBNA1 "druggability" suggests novel insights for Epstein-Barr virus inhibitor design | Q39743323 | ||
Nucleosome assembly proteins bind to Epstein-Barr virus nuclear antigen 1 and affect its functions in DNA replication and transcriptional activation | Q39804470 | ||
Role for G-quadruplex RNA binding by Epstein-Barr virus nuclear antigen 1 in DNA replication and metaphase chromosome attachment | Q39816429 | ||
Plasmid maintenance of derivatives of oriP of Epstein-Barr virus | Q39868910 | ||
Multiple regions within EBNA1 can link DNAs. | Q39872012 | ||
Cell cycle-dependent binding modes of the ran exchange factor RCC1 to chromatin | Q39883316 | ||
Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro | Q39927855 | ||
Inducible degradation of I kappa B alpha in vitro and in vivo requires the acidic C-terminal domain of the protein | Q40016147 | ||
A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthiness | Q40039701 | ||
Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines | Q40044261 | ||
Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes | Q40048949 | ||
Binding of EBNA-1 to DNA creates a protease-resistant domain that encompasses the DNA recognition and dimerization functions | Q40065691 | ||
Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance | Q40125313 | ||
Epstein-Barr virus (EBV) provides survival factors to EBV+ diffuse large B-cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV+ DLBCL. | Q40126382 | ||
Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing | Q40128647 | ||
Replication of latent Epstein-Barr virus genomes in Raji cells | Q40132478 | ||
Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways | Q40135893 | ||
Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model | Q40146526 | ||
Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men. | Q40206465 | ||
Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells | Q40233677 | ||
Epstein-Barr virus nuclear antigen 1 interacts with regulator of chromosome condensation 1 dynamically throughout the cell cycle | Q40296910 | ||
siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cells | Q40341019 | ||
Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency. | Q40375637 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 4 | |
P921 | main subject | evasion of host immune response | Q1660157 |
Epstein–Barr virus | Q6900 | ||
P577 | publication date | 2018-04-06 | |
P1433 | published in | Cancers | Q27722963 |
P1476 | title | EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers. | |
P478 | volume | 10 |
Q97905739 | Cross-species chromatin interactions drive transcriptional rewiring in Epstein-Barr virus-positive gastric adenocarcinoma |
Q60928950 | In Cellulo Protein-mRNA Interaction Assay to Determine the Action of G-Quadruplex-Binding Molecules |
Q92238951 | Modulation of Angiogenic Processes by the Human Gammaherpesviruses, Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus |
Q58567030 | Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis |
Q64104346 | Novel Therapeutics for Epstein⁻Barr Virus |
Q90356763 | STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency |
Q93079245 | Sneaking Out for Happy Hour: Yeast-Based Approaches to Explore and Modulate Immune Response and Immune Evasion |
Q96304633 | Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma |
Q90459120 | Tumor microenvironment predicts local tumor extensiveness in PD-L1 positive nasopharyngeal cancer |